Kyte JA - Search Results

1

Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.

Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA. Almåsbak H, et al. Among authors: kyte ja. Gene Ther. 2015 May;22(5):391-403. doi: 10.1038/gt.2015.4. Epub 2015 Feb 5. Gene Ther. 2015. PMID: 25652098

2

Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo.

Munthe LA, Kyte JA, Bogen B. Munthe LA, et al. Among authors: kyte ja. Eur J Immunol. 1999 Dec;29(12):4043-52. doi: 10.1002/(SICI)1521-4141(199912)29:12<4043::AID-IMMU4043>3.0.CO;2-E. Eur J Immunol. 1999. PMID: 10602015 Free article.

3

Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination.

Kyte JA, Kvalheim G, Aamdal S, Saebøe-Larssen S, Gaudernack G. Kyte JA, et al. Cancer Gene Ther. 2005 Jun;12(6):579-91. doi: 10.1038/sj.cgt.7700837. Cancer Gene Ther. 2005. PMID: 15818380

4

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients.

Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G. Mu LJ, et al. Among authors: kyte ja. Br J Cancer. 2005 Oct 3;93(7):749-56. doi: 10.1038/sj.bjc.6602761. Br J Cancer. 2005. PMID: 16136047 Free PMC article.

5

Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.

Kyte JA, Gaudernack G. Kyte JA, et al. Cancer Immunol Immunother. 2006 Nov;55(11):1432-42. doi: 10.1007/s00262-006-0161-7. Epub 2006 Apr 13. Cancer Immunol Immunother. 2006. PMID: 16612595 Free PMC article. Review.

6

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.

Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G. Kyte JA, et al. Cancer Gene Ther. 2006 Oct;13(10):905-18. doi: 10.1038/sj.cgt.7700961. Epub 2006 May 5. Cancer Gene Ther. 2006. PMID: 16710345 Clinical Trial.

7

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.

Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G. Kyte JA, et al. Cancer Immunol Immunother. 2007 May;56(5):659-75. doi: 10.1007/s00262-006-0222-y. Epub 2006 Sep 1. Cancer Immunol Immunother. 2007. PMID: 16947019 Free PMC article. Clinical Trial.

8

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.

Kyte JA, Trachsel S, Risberg B, thor Straten P, Lislerud K, Gaudernack G. Kyte JA, et al. Cancer Immunol Immunother. 2009 Oct;58(10):1609-26. doi: 10.1007/s00262-009-0670-2. Epub 2009 Feb 17. Cancer Immunol Immunother. 2009. PMID: 19221745 Free PMC article.

9

Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients.

Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S. Kyte JA, et al. Clin Cancer Res. 2011 Jul 1;17(13):4568-80. doi: 10.1158/1078-0432.CCR-11-0184. Epub 2011 May 17. Clin Cancer Res. 2011. PMID: 21586625 Clinical Trial.

10

Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.

Brunsvig PF, Kyte JA, Kersten C, Sundstrøm S, Møller M, Nyakas M, Hansen GL, Gaudernack G, Aamdal S. Brunsvig PF, et al. Among authors: kyte ja. Clin Cancer Res. 2011 Nov 1;17(21):6847-57. doi: 10.1158/1078-0432.CCR-11-1385. Epub 2011 Sep 14. Clin Cancer Res. 2011. PMID: 21918169 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page